第一单位:
Cancer Research UK Cambridge Institute, Cambridge, UK.
作者:
Geoff,Macintyre [1]
;
Teodora E,Goranova [1]
;
Dilrini,De Silva [1]
;
Darren,Ennis [2]
;
Anna M,Piskorz [1]
;
Matthew,Eldridge [1]
;
Daoud,Sie [3]
;
Liz-Anne,Lewsley [4]
;
Aishah,Hanif [4]
;
Cheryl,Wilson [4]
;
Suzanne,Dowson [2]
;
Rosalind M,Glasspool [5]
;
Michelle,Lockley [6]
;
Elly,Brockbank [7]
;
Ana,Montes [8]
;
Axel,Walther [9]
;
Sudha,Sundar [10]
;
Richard,Edmondson [11]
;
Geoff D,Hall [12]
;
Andrew,Clamp [13]
;
Charlie,Gourley [14]
;
Marcia,Hall [15]
;
Christina,Fotopoulou [16]
;
Hani,Gabra [17]
;
James,Paul [4]
;
Anna,Supernat [1]
;
David,Millan [18]
;
Aoisha,Hoyle [18]
;
Gareth,Bryson [18]
;
Craig,Nourse [2]
;
Laura,Mincarelli [2]
;
Luis Navarro,Sanchez [2]
;
Bauke,Ylstra [3]
;
Mercedes,Jimenez-Linan [19]
;
Luiza,Moore [19]
;
Oliver,Hofmann [20]
;
Florian,Markowetz [21]
;
Iain A,McNeish [22]
;
James D,Brenton [23]
作者单位:
Cancer Research UK Cambridge Institute, Cambridge, UK.
[1]
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
[2]
VU University Medical Center, Amsterdam, the Netherlands.
[3]
Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
[4]
Beatson West of Scotland Cancer Centre, Glasgow, UK.
[5]
Barts Cancer Institute, Queen Mary University of London, London, UK.;University College London Hospital, London, UK.
[6]
Barts Health NHS Trust, London, UK.
[7]
Guy's Hospital, London, UK.
[8]
Bristol Cancer Institute, Bristol, UK.
[9]
City Hospital, Birmingham, UK.
[10]
Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK.;Department of Obstetrics and Gynaecology, Manchester Academic Health Science Centre, St Mary's Hospital, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
[11]
St James's Institute of Oncology, Leeds, UK.
[12]
The Christie Hospital, Manchester, UK.
[13]
Nicola Murray Centre for Ovarian Cancer Research, MRC IGMM, University of Edinburgh, Edinburgh, UK.
[14]
Mount Vernon Cancer Centre, Northwood, UK.
[15]
Division of Cancer and Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College, London, UK.
[16]
Division of Cancer and Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College, London, UK.;Early Clinical Development, IMED Biotech Unit, AstraZeneca, Cambridge, UK.
[17]
Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK.
[18]
Addenbrooke's Hospital, Cambridge, UK.
[19]
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.;Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia.
[20]
Cancer Research UK Cambridge Institute, Cambridge, UK. Florian.Markowetz@cruk.cam.ac.uk.
[21]
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. i.mcneish@imperial.ac.uk.;Beatson West of Scotland Cancer Centre, Glasgow, UK. i.mcneish@imperial.ac.uk.;Division of Cancer and Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College, London, UK. i.mcneish@imperial.ac.uk.
[22]
Cancer Research UK Cambridge Institute, Cambridge, UK. James.Brenton@cruk.cam.ac.uk.;Addenbrooke's Hospital, Cambridge, UK. James.Brenton@cruk.cam.ac.uk.;Department of Oncology, University of Cambridge, Cambridge, UK. James.Brenton@cruk.cam.ac.uk.
[23]
DOI
10.1038/s41588-018-0179-8
PMID
30104763
发布时间
2025-05-30